SARS-CoV-2 attacks the body by latching onto a protein called ACE2, which sits on the surface of cells in your lungs, heart, kidneys, gut, and blood vessels. This widespread distribution of ACE2 is why COVID-19 can damage so many organs, not just the respiratory system. The virus hijacks your cells to replicate, and the immune response it triggers can be just as destructive as the virus itself.
How the Virus Gets Into Your Cells
The coronavirus is covered in spike proteins that act like molecular keys. These spikes bind to ACE2 receptors on human cells, and once attached, the spike undergoes a shape change that fuses the virus’s outer membrane with the cell membrane. This lets the virus’s genetic material slip inside, where it commandeers the cell’s machinery to produce copies of itself. Those copies then burst out to infect neighboring cells.
ACE2 receptors are especially dense in the lining of the nose, throat, and lungs, which is why the respiratory tract takes the initial hit. But they’re also found on cells in the intestines, kidneys, heart, and blood vessels, giving the virus potential access to nearly every major organ system.
What Happens in the Lungs
The lungs bear the brunt of a COVID-19 infection. Inside them, tiny air sacs called alveoli are where oxygen passes into your blood. The virus infects the cells lining these air sacs and triggers an aggressive immune response. White blood cells flood the area, releasing inflammatory molecules that, while targeting the virus, also damage the thin barrier between the air sacs and the surrounding blood vessels. Fluid and debris leak into spaces that should contain only air.
This process unfolds in stages. In the first phase, protein-rich fluid fills the alveoli, making it progressively harder to get oxygen into the bloodstream. Tiny clots can form in the surrounding capillaries, further choking off gas exchange. If the immune system clears the infection, the lungs shift into a repair phase: damaged cells are replaced, inflammation subsides, and function gradually returns. Recovery from mild infection typically takes about two weeks.
When this repair phase stalls or drags on, scar tissue can form in the air sacs, a condition called pulmonary fibrosis. Autopsy studies of patients who died from severe COVID-19 consistently show these features: fluid-filled alveoli, thickened membranes, widespread tiny blood clots, and in advanced cases, fibrotic scarring. This progression toward acute respiratory distress syndrome (ARDS) tends to occur roughly one week after symptoms begin, with the most severe cases needing mechanical ventilation around day 10.
The Immune System’s Double-Edged Sword
In severe COVID-19, the immune system can overshoot. Immune cells release a flood of signaling molecules, including IL-6, IL-1β, TNF-α, and others, in what’s often called a cytokine storm. This torrent of inflammatory signals doesn’t just fight the virus. It damages healthy tissue throughout the body, breaks down blood vessel walls, promotes clotting, and can push multiple organs toward failure simultaneously.
A key imbalance appears to drive this: certain inflammatory signals ramp up while the body’s first-line antiviral defenses (particularly a group of molecules called type I interferons) remain suppressed. The result is inflammation without effective viral control, the worst of both worlds. The severity of this cytokine imbalance closely tracks with how sick a person becomes and their risk of dying.
Typical Symptom Timeline
Symptoms usually appear four to five days after exposure, though the incubation period can range from 2 to 14 days. The illness often starts with fever, fatigue, dry cough, and muscle aches. Around day 5, some patients develop pneumonia. For most people, symptoms remain mild and resolve within two weeks.
For those who worsen, shortness of breath typically develops around day 6 or 7. Hospitalization, when needed, happens around day 7 to 8 from symptom onset. ARDS, the most dangerous lung complication, tends to set in around day 9. Severe cases that require intensive care can take three to six weeks to recover. With current variants (as of 2024), roughly 2% of people who test positive are hospitalized, and in-hospital death rates have dropped to very low levels, around 0.03% of those testing positive.
Effects on the Heart and Blood Vessels
COVID-19 has a notable impact on the cardiovascular system, though direct viral infection of the heart appears to be uncommon. While autopsy studies have found viral genetic material in a majority of heart tissue samples (about 62% in one German study of 39 patients), evidence that the virus actively replicates in heart muscle cells is rare. True myocarditis, meaning inflammation severe enough to damage the heart muscle, occurs in roughly 2% of hospitalized patients or fewer after careful pathological review.
The more common cardiovascular threat comes from the virus’s effects on blood vessels. The endothelial cells lining blood vessels express ACE2 and can be injured during infection. This endothelial damage, combined with the surge in inflammatory signals, creates conditions ripe for abnormal clotting. Microclots form in small vessels throughout the body, including in the lungs, kidneys, and brain. Larger clots can cause strokes or pulmonary embolisms. This clotting tendency is one of the distinguishing features of severe COVID-19 compared with other respiratory infections.
Kidney and Liver Damage
Acute kidney injury is a common complication in hospitalized COVID-19 patients. The kidneys are vulnerable for several reasons. Their cells express ACE2, making direct viral infection at least theoretically possible, though biopsy studies have been inconsistent on whether the virus actually infects kidney tissue. What’s more clearly established is that inflammation and tiny blood clots in the kidney’s delicate filtering units cause significant damage. Drops in blood pressure during severe illness further stress the kidneys by reducing their blood supply.
The liver can also take a hit. Abnormal liver function tests are common during COVID-19 infection, likely from a combination of the systemic inflammatory response, medication effects, and reduced oxygen delivery rather than direct viral invasion of liver cells.
Gut Symptoms and Why They Happen
Digestive symptoms are more common than many people expect. Nausea, vomiting, diarrhea, abdominal pain, and loss of appetite affect a significant portion of patients. The first confirmed COVID-19 case in the United States, in fact, presented with gastrointestinal symptoms alongside respiratory ones.
The gut lining is one of the body’s largest surfaces exposed to the outside world, and it’s rich in ACE2 receptors. The virus can directly damage intestinal cells, increasing the gut’s permeability to bacteria and other harmful substances. Infection also disrupts the gut microbiome, the community of bacteria that normally aids digestion and helps regulate the immune system. When ACE2 function is knocked out by viral infection, it interferes with the absorption of certain amino acids, which can trigger intestinal inflammation and diarrhea. On top of all this, the systemic cytokine storm can inflame the gut from the inside out.
Effects on the Brain and Nervous System
COVID-19 can cause a range of neurological symptoms, from the well-known loss of smell and taste to headaches, confusion, dizziness, and in severe cases, strokes or encephalitis. The virus appears to disrupt the blood-brain barrier, the tightly sealed layer of cells that normally prevents pathogens and inflammatory molecules from entering brain tissue.
Once this barrier is compromised, inflammatory signals from the body flood into the brain. Specialized immune cells in the brain become activated, amplifying local inflammation. This neuroinflammation may explain the “brain fog,” difficulty concentrating, and cognitive problems that many patients report, even after mild infections. Direct viral invasion of brain tissue remains a subject of debate, but the indirect damage from inflammation and vascular injury is well documented.
Long COVID and Lasting Effects
For some people, symptoms persist for weeks, months, or even years after the initial infection clears. This condition, broadly called Long COVID, appears to involve several overlapping mechanisms. One leading theory is that fragments of the virus, or even low levels of replicating virus, hide in tissue reservoirs throughout the body, continuously stimulating the immune system long after the acute illness has passed.
This viral persistence may drive ongoing immune dysfunction, including exhaustion of certain immune cells (particularly T cells), chronic low-grade inflammation, and the production of autoantibodies that mistakenly attack the body’s own tissues. Damage to the lining of blood vessels (endothelial dysfunction) and disruptions to normal metabolism have also been implicated. Together, these processes help explain why Long COVID can affect so many different systems simultaneously, producing fatigue, cognitive difficulties, heart palpitations, digestive issues, and exercise intolerance in various combinations that differ from person to person.